Treating IgG4-related disease with rituximab 233114

Dr James Galloway and Dr Justin Mason, Imperial College London, UK discuss a paper published in...

Dr James Galloway and Dr Justin Mason, Imperial College London, UK discuss a paper published in the Journal by John Stone et al. who looked at patients with IgG4 related disease treated with rituximab, to determine if there were potential markers to predict relapse in patients after treatment. They discuss the potential implications for future treatment, drawbacks of the study and possible future research directions for the disease.

Dr Steven Zhao on comorbidities and disease activity in axSpA 5 días 07:54 Dr Marwan Bukhari talks to Dr Helena Marzo-Ortega on the use of MRI in the diagnosis of axSpA +1 año 06:07 RA patient access to DMARDs in Norway +1 año 05:59 Dr Gouri Koduri on patient perceptions of comorbidities +1 año 11:54 Dr Steven Zhao on comorbidities and disease activity in axSpA 5 días 07:54 Ver más en APP Comentarios del episodio 5w124b